New Labour government backs pharma reform in UK
“Change begins now,” said the UK’s new prime minister, Sir Keir Starmer, in his 5 July victory speech. Ending the…
“Change begins now,” said the UK’s new prime minister, Sir Keir Starmer, in his 5 July victory speech. Ending the…
There is a critical need for collaboration between the pharmaceutical and medical device industries to develop wound management solutions, says…
AI developers in the biotechnology field need to watch out for potential “bad actors”, who could use the technology for…
Leading up to the UK Spring Budget announcement this week, Chancellor of the Exchequer Jeremy Hunt declared a £360m ($456.6m)…
Rare disease clinical research is no longer an afterthought for pharmaceutical companies with rapid approvals and increased investment in this…
The UK has re-joined the EU’s Horizon Europe science research programme after the country’s post-Brexit absence and long-stalled talks. British…
Despite a cautious outlook at the beginning of 2023, the latest data from the Office for National Statistics (ONS) suggests…
Thermo Fisher Scientific has completed its acquisition of data intelligence company CorEvitas for $912.5m in cash. Thermo Fisher first announced…
Patients with erectile dysfunction (ED) will now be able to access a topical treatment without the need for a prescription…
The US Food and Drug Administration (FDA) has issued a press release providing recommendations on how to handle the recent…